NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 40 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $37,000 | -7.5% | 18,385 | 0.0% | 0.00% | – |
| Q4 2020 | $40,000 | -20.0% | 18,385 | 0.0% | 0.00% | – |
| Q3 2020 | $50,000 | -30.6% | 18,385 | 0.0% | 0.00% | – |
| Q2 2020 | $72,000 | +414.3% | 18,385 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -39.1% | 18,385 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +76.9% | 18,385 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | +8.3% | 18,385 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | – | 18,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |